Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fractional CO2 Laser and Calcipotriol/Betamethasone Ointment in Plaque Psoriasis
NCT06011083Completed
- Sponsor
- Assiut University
- Start
- Aug 2022
- Primary completion
- Feb 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of AKP01 and betamethasone dipropionate spray 0.05% in plaque psoriasis, sponsored by Assiut University. Primary endpoint: Psoriasis severity (TES) at 24 weeks. Started Aug 2022; status: completed.
02
Drugs
AKP01betamethasone dipropionate spray 0.05%
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT06011083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06011083.